42.80
-0.80
(-1.83%)
As of 8:15:58 AM GMT+1. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.94M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BOULDING MARK ELLIOTT Officer | Sale at price 44.50 - 45.34 per share. | Direct | 158,871 | Jan 8, 2025 |
PAUWELS ERIC Chief Executive Officer | Sale at price 44.50 - 45.34 per share. | Direct | 167,551 | Jan 8, 2025 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Sale at price 44.50 - 45.34 per share. | Indirect | 133,674 | Jan 8, 2025 |
GOLDEN LEE SCOTT Officer | Sale at price 44.50 - 45.34 per share. | Direct | 90,036 | Jan 8, 2025 |
UTTER CHRISTINE MARIE Officer | Sale at price 44.50 - 45.34 per share. | Direct | 132,493 | Jan 8, 2025 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 44.50 - 45.34 per share. | Direct | 204,007 | Jan 8, 2025 |
SOUTHWELL DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
ZELDIS JEROME B. M.D., PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
BOULDING MARK ELLIOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
STEELE GLENN D JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
SCHMERTZLER MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
PAUWELS ERIC Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
ALMSTEAD NEIL GREGORY Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jan 3, 2025 |
JACOBSON ALLAN STEVEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
REEVE EMMA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
GOLDEN LEE SCOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
UTTER CHRISTINE MARIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
OKEY STEPHANIE S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
KLEIN MATTHEW B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
SMITH MARY L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
YOUNG ALETHIA R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
GRAVIER PIERRE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 45.16 per share. | Direct | 373,880 | Dec 31, 2024 |
BOULDING MARK ELLIOTT Officer | Sale at price 52.17 - 54.14 per share. | Direct | 5,022,334 | Dec 3, 2024 |
BOULDING MARK ELLIOTT Officer | Conversion of Exercise of derivative security at price 33.02 - 51.00 per share. | Direct | 4,705,970 | Dec 3, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Sale at price 50.52 - 52.42 per share. | Direct | 1,235,897 | Dec 2, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Conversion of Exercise of derivative security at price 30.86 - 51.00 per share. | Direct | 982,320 | Dec 2, 2024 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Sale at price 51.85 - 52.76 per share. | Indirect | 3,727,958 | Dec 2, 2024 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Conversion of Exercise of derivative security at price 51.00 per share. | Indirect | 3,652,110 | Dec 2, 2024 |
UTTER CHRISTINE MARIE Officer | Sale at price 51.34 - 52.45 per share. | Direct | 921,585 | Dec 2, 2024 |
UTTER CHRISTINE MARIE Officer | Conversion of Exercise of derivative security at price 51.00 per share. | Direct | 907,800 | Dec 2, 2024 |
GRAVIER PIERRE Chief Financial Officer | Sale at price 34.02 per share. | Direct | 77,200 | Jul 16, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Sale at price 38.24 per share. | Direct | 764,800 | May 22, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Conversion of Exercise of derivative security at price 26.42 per share. | Direct | 528,400 | May 22, 2024 |
SOUTHWELL DAVID P Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 8, 2024 |
GOLDEN LEE SCOTT Officer | Sale at price 32.82 per share. | Direct | 5,744 | May 7, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 24.89 per share. | Direct | 83,669 | Apr 19, 2024 |
PAUWELS ERIC Chief Executive Officer | Sale at price 25.14 per share. | Direct | 19,781 | Apr 17, 2024 |
KLEIN MATTHEW B Chief Executive Officer | Sale at price 25.14 per share. | Direct | 32,851 | Apr 17, 2024 |
GOLDEN LEE SCOTT Officer | Sale at price 28.37 per share. | Direct | 14,923 | Apr 2, 2024 |
SOUTHWELL DAVID P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
ZELDIS JEROME B. M.D., PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
BOULDING MARK ELLIOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
STEELE GLENN D JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
SCHMERTZLER MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
PAUWELS ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
ALMSTEAD NEIL GREGORY Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Feb 15, 2024 |
JACOBSON ALLAN STEVEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
REEVE EMMA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
GOLDEN LEE SCOTT Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 15, 2024 |
Related Tickers
42Z.F Revolution Medicines, Inc.
38.00
-2.06%
ENSCW Leisure Acquisition Corp.
0.0297
+41.43%
ANEB Anebulo Pharmaceuticals, Inc.
1.5400
-1.28%
BRNS Barinthus Biotherapeutics plc
1.0100
-6.48%
ABVC ABVC BioPharma, Inc.
0.5236
-1.86%
ELTX Elicio Therapeutics, Inc.
7.74
+7.50%
ACXP Acurx Pharmaceuticals, Inc.
0.8716
+5.25%
EDSA Edesa Biotech, Inc.
2.2300
+28.90%
NKTX Nkarta, Inc.
2.4900
-1.58%
KOD Kodiak Sciences Inc.
8.01
-3.61%